نتایج جستجو برای: hsv 2

تعداد نتایج: 2530447  

Alireza Fotouhi Ghiam Marjan Movaseghii Maryam Kasraeian,

Background: Herpes Simplex Virus (HSV) Type 2 is a widespread human infectious agent responsible for persistent and latent infections. Objectives: To estimate the regional seroprevalence of anti HSV-2 antibody in Shiraz, Iran and to investigate the possible correlation of seropositivity with malignant changes in subjects’ Papanicolaou (Pap) tests. Methods: Data were collected in a cross-section...

2014
Pengwei Zhang Lining Xie John W. Balliet Danilo R. Casimiro Feng Yao

We recently constructed a novel non-replicating dominant-negative HSV-2 recombinant viral vaccine (CJ2-gD2) capable of expressing various HSV-2 antigens that are dominant targets of HSV-2-specific CD8 T-cell response. Importantly, CJ2-gD2 expresses gD2, the HSV-2 major antigen glycoprotein D, as efficiently as wild-type HSV-2 infection and can lead to a nearly 500-fold reduction in wild-type HS...

Journal: :International Journal of Infectious Diseases 2021

Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During treatment meningococcal meningitis, patient developed quadriparesis and later diagnosed as mimicking ICU-acquired weakness. The emphasizes importance excluding viral myelitis befo...

2014
Jingya Xia Ronald L. Veselenak Summer R. Gorder Nigel Bourne Gregg N. Milligan

Despite its importance in modulating HSV-2 pathogenesis, the nature of tissue-resident immune memory to HSV-2 is not completely understood. We used genital HSV-2 infection of guinea pigs to assess the type and location of HSV-specific memory cells at peripheral sites of HSV-2 infection. HSV-specific antibody-secreting cells were readily detected in the spleen, bone marrow, vagina/cervix, lumbos...

Journal: :The Indian journal of medical research 2004
Nizami Duran Fugen Yarkin Cuneyt Evruke Fatih Koksal

BACKGROUND & OBJECTIVES A large proportion of individuals with serologic evidence of infection with herpes simplex virus type 2 (HSV-2) are asymptomatic. HSV-2 is the main cause of genital herpes infections. The acquisition of genital herpes during pregnancy has been associated with spontaneous abortion, premature labour and congenital and neonatal herpes. The present study was undertaken to de...

Journal: :Journal of clinical microbiology 1990
J J McSharry R Costantino M B McSharry R A Venezia J M Lehman

Murine monoclonal antibodies (MAbs) against herpes simplex virus type 1 and 2 (HSV-1 and -2, respectively) nuclear antigens were used to identify cells infected with HSV-1 or -2 by indirect immunofluorescence in conjunction with flow cytometry after virus amplification of MRC-5 cell monolayers. The results indicate that MAbs Q1, Q2, and H-640 detect HSV-1- and HSV-2-infected cells, MAb SD-1 det...

Journal: :Indian journal of dermatology, venereology and leprology 2005
K N Shivaswamy Devinder Mohan Thappa T J Jaisankar S Sujatha

BACKGROUND In Asia, HSV seroprevalence studies are sparse and they have recorded lower prevalence of HSV infection, especially HSV-2. AIMS To ascertain the seroprevalence of HSV-1 and HSV-2 in patients attending a STD clinic in a referral hospital in south India and to compare it with a control group. METHODS The study included 135 consecutive STD cases having history of ulcerative or non-u...

2017
Peter B Gilbert Jean-Louis Excler Georgia D Tomaras Lindsay N Carpp Barton F Haynes Hua-Xin Liao David C Montefiori Supachai Rerks-Ngarm Punnee Pitisuttithum Sorachai Nitayaphan Jaranit Kaewkungwal Gustavo H Kijak Sodsai Tovanabutra Donald P Francis Carter Lee Faruk Sinangil Phillip W Berman Nakorn Premsri Prayura Kunasol Robert J O'Connell Nelson L Michael Merlin L Robb Rhoda Morrow Lawrence Corey Jerome H Kim

BACKGROUND In the HIV-1 vaccine trial RV144, ALVAC-HIV prime with an AIDSVAX® B/E boost reduced HIV-1 acquisition by 31% at 42 months post first vaccination. The bivalent AIDSVAX® B/E vaccine contains two gp120 envelope glycoproteins, one from the subtype B HIV-1 MN isolate and one from the subtype CRF01_AE A244 isolate. Each envelope glycoprotein harbors a highly conserved 27-amino acid HSV-1 ...

2010
William P. Halford Ringo Püschel Brandon Rakowski

Herpes simplex virus 1 (HSV-1) ICP0(-) mutants are interferon-sensitive, avirulent, and elicit protective immunity against HSV-1 (Virol J, 2006, 3:44). If an ICP0(-) mutant of herpes simplex virus 2 (HSV-2) exhibited similar properties, such a virus might be used to vaccinate against genital herpes. The current study was initiated to explore this possibility. Several HSV-2 ICP0(-) mutant viruse...

Journal: :Journal of virology 1996
D E Goade R Bell T Yamada G J Mertz S Jenison

Herpes simplex virus type 2 (HSV-2) glycoprotein B (gB-2) gene segments were expressed as recombinant proteins in Escherichia coli. gB-2 recombinant proteins were reacted with human serum immunoglobulin G (IgG) antibodies in Western immunoblot assays. Initially, samples were tested for the presence of HSV-1-specific antibodies and HSV-2-specific antibodies by using HSV-infected cell lysates as ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید